INSIGHTS •   •   •   •   •   •   •   •   •   •   •  

Dec 10

Written by: Ken Kahtava
12/10/2012 3:05 PM  RssIcon

To say that patients and patient advocacy groups are playing an important role in the evolving drug development ecosystem would be an understatement.  This fact was front and center at the recent Partnering for Cures conference, hosted by FasterCures, in late November this year.  We have much to talk (blog) about as it relates to the conference, but in the meantime, we couldn't agree more with Mikael Dolan of Pfizer, in his Forbes article.

Your name:
Gravatar Preview
Your email:
(Optional) Email used only to show Gravatar.
Your website:
Security Code
Enter the code shown above in the box below
Add Comment   Cancel